BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9815677)

  • 1. 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas.
    Fontanini G; Vignati S; Chiné S; Lucchi M; Mussi A; Angeletti CA; Ménard S; Castronovo V; Bevilacqua G
    Clin Cancer Res; 1997 Feb; 3(2):227-31. PubMed ID: 9815677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer.
    Meert AP; Martin B; Verdebout JM; Paesmans M; Berghmans T; Ninane V; Sculier JP
    Lung Cancer; 2004 Jun; 44(3):295-301. PubMed ID: 15140542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
    Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
    Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
    Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours.
    Pelosi G; Pasini F; Bresaola E; Bogina G; Pederzoli P; Biolo S; Menard S; Zamboni G
    J Pathol; 1997 Sep; 183(1):62-9. PubMed ID: 9370949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Powis G; Souglakos J; Sivridis E; Georgoulias V; Gatter KC; Harris AL
    Clin Cancer Res; 2001 Oct; 7(10):3087-91. PubMed ID: 11595699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
    Quinlan DC; Davidson AG; Summers CL; Warden HE; Doshi HM
    Cancer Res; 1992 Sep; 52(17):4828-31. PubMed ID: 1324796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer].
    de Manzoni G; Guglielmi A; Di Leo A; Tomezzoli A; Laterza E; Bonfiglio M; Biolo S; Tedesco P; Borzellino G
    G Chir; 1998; 19(8-9):323-8. PubMed ID: 9734182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
    Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
    Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
    Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
    Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG; van der Valk P; Span SW; Ludwig I; Smit EF; Kruyt FA; Pinedo HM; van Tinteren H; Giaccone G
    Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminin, Her2/neu and Ki-67 as prognostic factors in non-small cell lung cancer.
    Szelachowska J; Jeleń M
    Rocz Akad Med Bialymst; 2004; 49():256-61. PubMed ID: 15631353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.
    Tan DF; Li Q; Rammath N; Beck A; Wiseman S; Anderson T; al-Salameh A; Brooks J; Bepler G
    Anticancer Res; 2003; 23(2C):1665-72. PubMed ID: 12820438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.